Critical Factors and Economic Methods for Regulatory Impact Assessment in the Medical Device Industry

References

• OECD. Measuring regulatory performance. OECD; September 21, 2020. Available from: http://www.oecd.org/gov/regulatory-policy/measuring-regulatory-performance.htm. Accessed January 6, 2022.
   Google Scholar
• Faulkner A. Tissue engineered technologies: regulatory pharmaceuticalization in the European Union. Innov Eur J Soc Sci Res. 2012;25(4):389–408. doi:10.1080/13511610.2012.723333
   Web of Science ®Google Scholar
• FDA. Advancing regulatory science. U.S. Food & Drug Administration; October 4, 2019. Available from: https://www.fda.gov/science-research/science-and-research-special-topics/advancing-regulatory-science. Accessed January 6, 2022.
   Google Scholar
• ITU. Using regulatory impact analysis to improve decision making in the ICT sector. International Telecommunication Union; Union internationale des télécommunications; 2014. Available from: http://handle.itu.int/11.1002/pub/80cc9798-en. Accessed January 6, 2022.
   Google Scholar
• Maresova P, Hajek L, Krejcar O, Storek M, Kuca K. New regulations on medical devices in Europe: are they an opportunity for growth? Adm Sci. 2020;10(1):16. doi:10.3390/admsci10010016
   Web of Science ®Google Scholar
• Rothwell R, Zegveld WC. Reindustrialization and Technology. Sharpe; 1985.
   Google Scholar
• Bonnin Roca J, O’Sullivan E. The role of regulators in mitigating uncertainty within the valley of death. Technovation. 2020:102157. doi:10.1016/j.technovation.2020.102157
   Web of Science ®Google Scholar
• Johnson JA. FDA regulation of medical devices. In: Medical Devices & the FDA: Regulation, User Fees & Tort Claims. Nova Science; Gazelle [distributor]; 2013:1–38.
   Google Scholar
• Ganz RA. The impact of health care reform on innovation and new technology. Gastrointest Endosc Clin N Am. 2012;22(1):109–120. doi:10.1016/j.giec.2011.08.006
   PubMedGoogle Scholar
• Pane J, Coloma PM, Verhamme KMC, Sturkenboom MCJM, Rebollo I. Evaluating the safety profile of non-active implantable medical devices compared with medicines. Drug Saf. 2017;40(1):37–47. doi:10.1007/s40264-016-0474-1
   PubMed Web of Science ®Google Scholar
• Maresova P, Rezny L, Peter L, Hajek L, Lefley F. Do regulatory changes seriously affect the medical devices industry? Evidence from the Czech Republic. Front Public Health. 2021;9:666453. doi:10.3389/fpubh.2021.666453
   PubMed Web of Science ®Google Scholar
• Medical devices in the EU: a global leader in safety, availability and innovation; November, 2015. Available from: https://www.medtecheurope.org/news-and-events/default/medical-devices-in-the-eu-a-global-leader-in-safety-availability-and-innovation/. Accessed January 6, 2022.
   Google Scholar
• Wisła R, Sierotowicz T. Innovation in the pharmaceutical and medical technologies industries of Poland. WIPO World Intellectual Property Organization; 2018. Available from: https://www.wipo.int/edocs/pubdocs/en/wipo_pub_econstat_wp_45.pdf. Accessed January 6, 2022.
   Google Scholar
• Yamaue H. Innovation of Diagnosis and Treatment for Pancreatic Cancer. SPRINGER Verlag; 2017.
   Google Scholar
• MedTech Europe. MedTech Europe, from diagnosis to cure – homepage; 2020. Available from: https://www.medtecheurope.org/. Accessed January 1, 2020.
   Google Scholar
• Council of the European Union. Regulation (EU) 2017/745 of the European Parliament and of the council of 5 April 2017 on medical devices, Amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and Repealing council directives 90/385/EEC and 93/42/EEC; 2017. Available from: https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=CELEX%3A32017R0745. Accessed January 1, 2020.
   Google Scholar
• EUnetHTA. HTA Core Model®. EUnetHTA; 2021. https://www.eunethta.eu/hta-core-model/. Accessed October 27, 2021.
   Google Scholar
• Burlea-Schiopoiu A, Ferhati K. The managerial implications of the key performance indicators in healthcare sector: a cluster analysis. Healthcare. 2020;9(1):19. doi:10.3390/healthcare9010019
   Web of Science ®Google Scholar
• Brockis E, Marsden G, Cole A, Devlin N. A review of NICE methods across health technology assessment programmes: differences, justifications and implications. Office of Health Economics Research; 2016. Available from: https://www.ohe.org/system/files/private/publications/NICE%20HTA%20methods%20RP%20FINAL_0.pdf. Accessed January 6, 2022.
   Google Scholar
• Echchakoui S. Why and how to merge Scopus and Web of Science during bibliometric analysis: the case of sales force literature from 1912 to 2019. J Mark Anal. 2020;8(3):165–184. doi:10.1057/s41270-020-00081-9
   Google Scholar
• Moher D, Liberati A, Tetzlaff J, Altman DG; The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097. doi:10.1371/journal.pmed.1000097
   PubMed Web of Science ®Google Scholar
• PRISMA. PRISMA flow diagram; 2021. Available from: http://prisma-statement.org/prismastatement/flowdiagram.aspx. Accessed January 6, 2022.
   Google Scholar
• Guerra-Bretaña RM, Flórez-Rendón AL. Impact of regulations on innovation in the field of medical devices. Res Biomed Eng. 2018;34(4):356–367. doi:10.1590/2446-4740.180054
   Google Scholar
• Gruska M, Aigner G, Altenberger J, et al. Recommendations on the utilization of telemedicine in cardiology. Wien Klin Wochenschr. 2020;132(23–24):782–800. doi:10.1007/s00508-020-01762-2
   PubMed Web of Science ®Google Scholar
• Wright SJ, Paulden M, Payne K. Implementing interventions with varying marginal cost-effectiveness: an application in precision medicine. Med Decis Making. 2020;40(7):924–938. doi:10.1177/0272989X20954391
   PubMed Web of Science ®Google Scholar
• Heidt B, Siqueira W, Eersels K, et al. Point of care diagnostics in resource-limited settings: a review of the present and future of PoC in its most needed environment. Biosensors. 2020;10(10):133. doi:10.3390/bios10100133
   PubMedGoogle Scholar
• Plun-Favreau J, Immonen-Charalambous K, Steuten L, et al. Enabling equal access to molecular diagnostics: What are the implications for policy and health technology assessment? Public Health Genomics. 2016;19(3):144–152. doi:10.1159/000446532
   PubMed Web of Science ®Google Scholar
• Gelijns AC, Russo MJ, Hong KN, Brown LD, Ascheim DD, Moskowitz AJ. Dynamics of device innovation: implications for assessing value. Int J Technol Assess Health Care. 2013;29(4):365–373. doi:10.1017/S0266462313000561
   PubMed Web of Science ®Google Scholar
• Miesler T, Wimschneider C, Brem A, Meinel L. Frugal innovation for point-of-care diagnostics controlling outbreaks and epidemics. ACS Biomater Sci Eng. 2020;6(5):2709–2725. doi:10.1021/acsbiomaterials.9b01712
   PubMed Web of Science ®Google Scholar
• Markiewicz K, Van Til J, IJzerman M. Early assessment of medical devices in development for company decision making: an exploration of best practices. J Commer Biotechnol. 2017;23(2). doi:10.5912/jcb780
   PubMedGoogle Scholar
• Blüher M, Saunders SJ, Mittard V, Torrejon Torres R, Davis JA, Saunders R. Critical review of European health-economic guidelines for the health technology assessment of medical devices. Front Med. 2019;6:278. doi:10.3389/fmed.2019.00278
   Web of Science ®Google Scholar
• Scannell P, Cormican K. Spinning out of control? How academic spinoff formation overlooks medical device regulations. J Technol Manag Innov. 2019;14(3):82–92. doi:10.4067/S0718-27242019000300082
   Google Scholar
• Jogova M, Shaw J, Jamieson T. The regulatory challenge of mobile health: lessons for Canada. Healthc Policy Polit Santé. 2019;14(3):19–28. doi:10.12927/hcpol.2019.25795
   PubMedGoogle Scholar
• Vallespin B, Cornet J, Kotzeva A. Ensuring evidence-based safe and effective mHealth applications. In: Evidence-Based Health Informatics. Studies in Health Technology and Informatics. IOS Press; 2016:248–261. doi:10.3233/978-1-61499-635-4-248
   Google Scholar
• Singh MD, Russ J, Terzidis O. The impact of the Obamacare excise tax on innovation and entrepreneurship early empirical findings. Int J Innov Sci. 2015;7(2):75–90. doi:10.1260/1757-2223.7.2.75
   Google Scholar
• Bolka EM. The medical device excise tax: an unfair burden. Indiana Law J. 2014;89(4):1691–1722.
   Web of Science ®Google Scholar
• White SK, Walters AN. Assessing risk by analogy: a case study of us medical device risk management policy. Health Risk Soc. 2018;20(7–8):358–378. doi:10.1080/13698575.2018.1554802
   Web of Science ®Google Scholar
• Howard J. Balancing innovation and medical device regulation: the case of modern metal-on-metal hip replacements. Med Devices Evid Res. 2016;9:267–275. doi:10.2147/MDER.S113067
   Google Scholar
• Richards N, Hudson I. UK medicines regulation: responding to current challenges: UK medicines regulation: responding to current challenges. Br J Clin Pharmacol. 2016;82(6):1471–1476. doi:10.1111/bcp.13077
   PubMed Web of Science ®Google Scholar
• Bowsher K, Civillico EF, Coburn J, et al. Brain–computer interface devices for patients with paralysis and amputation: a meeting report. J Neural Eng. 2016;13(2):023001. doi:10.1088/1741-2560/13/2/023001
   PubMed Web of Science ®Google Scholar
• De Maria C, Di Pietro L, Díaz Lantada A, et al. Safe innovation: on medical device legislation in Europe and Africa. Health Policy Technol. 2018;7(2):156–165. doi:10.1016/j.hlpt.2018.01.012
   Web of Science ®Google Scholar
• Boudard A, Martelli N, Prognon P, Pineau J. Clinical studies of innovative medical devices: what level of evidence for hospital-based health technology assessment?: Innovative medical devices and level of evidence. J Eval Clin Pract. 2013;19(4):697–702. doi:10.1111/jep.12024
   PubMed Web of Science ®Google Scholar
• Sauerland S, Brockhaus AC, Fujita-Rohwerder N, Saad S. Approaches to assessing the benefits and harms of medical devices for application in surgery. Langenbecks Arch Surg. 2014;399(3):279–285. doi:10.1007/s00423-014-1173-y
   PubMed Web of Science ®Google Scholar
• Lennox K. Substantially unequivalent: reforming FDA regulation of medical devices. Univ Ill LAW Rev. 2014;2014(4):1363–1400.
   Google Scholar
• Gardner J. A history of deep brain stimulation: technological innovation and the role of clinical assessment tools. Soc Stud Sci. 2013;43(5):707–728. doi:10.1177/0306312713483678
   Web of Science ®Google Scholar
• Altenstetter C. Medical device regulation and nanotechnologies: determining the role of patient safety concerns in policymaking: medical device regulation. Law Policy. 2011;33(2):227–255. doi:10.1111/j.1467-9930.2010.00337.x
   Web of Science ®Google Scholar
• Kale D. Mind the gap: investigating the role of collective action in the evolution of Indian medical device regulation. Technol Soc. 2019;59:101121. doi:10.1016/j.techsoc.2019.03.004
   Web of Science ®Google Scholar
• Munos B, Baker PC, Bot BM, et al. Mobile health: the power of wearables, sensors, and apps to transform clinical trials: mobile technology and clinical trials. Ann N Y Acad Sci. 2016;1375(1):3–18. doi:10.1111/nyas.13117
   PubMed Web of Science ®Google Scholar
• Onodera R, Sengoku S. Innovation process of mHealth: an overview of FDA-approved mobile medical applications. Int J Med Inf. 2018;118:65–71. doi:10.1016/j.ijmedinf.2018.07.004
   PubMed Web of Science ®Google Scholar
• Ravizza A, De Maria C, Di Pietro L, Sternini F, Audenino AL, Bignardi C. Comprehensive review on current and future regulatory requirements on wearable sensors in preclinical and clinical testing. Front Bioeng Biotechnol. 2019;7:313. doi:10.3389/fbioe.2019.00313
   PubMed Web of Science ®Google Scholar
• Drukker L, Noble JA, Papageorghiou AT. Introduction to artificial intelligence in ultrasound imaging in obstetrics and gynecology. Ultrasound Obstet Gynecol. 2020;56(4):498–505. doi:10.1002/uog.22122
   PubMed Web of Science ®Google Scholar
• Kesavan P, Dy CJ. Impact of health care reform on technology and innovation. Hand Clin. 2020;36(2):255–262. doi:10.1016/j.hcl.2020.01.008
   PubMed Web of Science ®Google Scholar
• Ibrahim N, Gillette N, Patel H, Peiris V. Regulatory science, and how device regulation will shape our future. Pediatr Cardiol. 2020;41(3):469–474. doi:10.1007/s00246-020-02296-0
   PubMed Web of Science ®Google Scholar
• Onur I, Söderberg M. The impact of regulatory review time on incremental and radical innovation: evidence from the high-risk medical device market. J Regul Econ. 2020;57(2):134–158. doi:10.1007/s11149-020-09401-4
   Web of Science ®Google Scholar
• Grennan M, Town RJ. Regulating innovation with uncertain quality: information, risk, and access in medical devices. Am Econ Rev. 2020;110(1):120–161. doi:10.1257/aer.20180946
   Web of Science ®Google Scholar
• Letourneur D, Joyce K, Chauvierre C, Bayon Y, Pandit A. Enabling MedTech translation in academia: redefining value proposition with updated regulations. Adv Healthc Mater. 2021;10(1):2001237. doi:10.1002/adhm.202001237
   Web of Science ®Google Scholar
• Vasiljeva K, Van Duren BH, Pandit H. Changing device regulations in the European Union: impact on research, innovation and clinical practice. Indian J Orthop. 2020;54(2):123–129. doi:10.1007/s43465-019-00013-5
   PubMed Web of Science ®Google Scholar
• Wilkinson B, van Boxtel R. The medical device regulation of the European Union intensifies focus on clinical benefits of devices. Ther Innov Regul Sci. 2020;54(3):613–617. doi:10.1007/s43441-019-00094-2
   PubMed Web of Science ®Google Scholar
• Dai Z, Ma Y, Li Q. China’s particle therapy equipment market: opportunities outweigh challenges. Front Public Health. 2020;8:602776. doi:10.3389/fpubh.2020.602776
   PubMed Web of Science ®Google Scholar
• Health Information and Quality Authority. Guidelines for the economic evaluation of health technologies in Ireland; September 28, 2020. Available from: https://www.hiqa.ie/reports-and-publications/health-technology-assessment/guidelines-economic-evaluation-health. Accessed January 6, 2022.
   Google Scholar
• Di Pietro L, Botte E, Granati R, et al. Teaching design standards and regulations on medical devices through a collaborative project-based learning approach. Int J Eng Educ. 2019;35(6A):1803–1815.
   Google Scholar
• Adler N, Liebert V. Joint impact of competition, ownership form and economic regulation on airport performance and pricing. Transp Res Part Policy Pract. 2014;64:92–109. doi:10.1016/j.tra.2014.03.008
   Web of Science ®Google Scholar
• Erdman AG, Keefe DF, Schiestl R. Grand challenge: applying regulatory science and big data to improve medical device innovation. IEEE Trans Biomed Eng. 2013;60(3):700–706. doi:10.1109/TBME.2013.2244600
   PubMed Web of Science ®Google Scholar
• Franco C, Pieri F, Venturini F. Product market regulation and innovation efficiency. J Product Anal. 2016;45(3):299–315. doi:10.1007/s11123-015-0441-3
   Web of Science ®Google Scholar
• Huang Y, Söder L. Evaluation of economic regulation in distribution systems with distributed generation. Energy. 2017;126:192–201. doi:10.1016/j.energy.2017.03.019
   Web of Science ®Google Scholar
• Joskow PL, Rose NL. The effects of economic regulation. In: Schmalensee R, Willig R, editors. Handbook of Industrial Organization. 1st ed. Vol. 2, MIT; 1989:1449–1506.
   Google Scholar
• Musshoff O, Hirschauer N. Using business simulation games in regulatory impact analysis – the case of policies aimed at reducing nitrogen leaching. Appl Econ. 2014;46(25):3049–3060. doi:10.1080/00036846.2014.920482
   Web of Science ®Google Scholar
• Parker D, Kirkpatrick C. Measuring Regulatory Performance. The Economic Impact of Regulatory Policy: A Literature Review of Quantitative Evidence. OECD; 2012.
   Google Scholar
• Radcliffe JC. Water recycling in Australia – during and after the drought. Environ Sci Water Res Technol. 2015;1(5):554–562. doi:10.1039/C5EW00048C
   Google Scholar
• Simões P, Marques RC. Influence of regulation on the productivity of waste utilities. What can we learn with the Portuguese experience? Waste Manag. 2012;32(6):1266–1275. doi:10.1016/j.wasman.2012.02.004
   PubMed Web of Science ®Google Scholar
• Keyaerts N, Delarue E, Rombauts Y, D’haeseleer W. Impact of unpredictable renewables on gas-balancing design in Europe. Appl Energy. 2014;119:266–277. doi:10.1016/j.apenergy.2014.01.011
   Web of Science ®Google Scholar
• Cossent R, Gómez T, Olmos L. Large-scale integration of renewable and distributed generation of electricity in Spain: current situation and future needs. Energy Policy. 2011;39(12):8078–8087. doi:10.1016/j.enpol.2011.09.069
   Web of Science ®Google Scholar
• Vidal C, Beuscart R, Chevallier T Contribution of methodologies adapted to clinical trials focusing on high risk medical devices: In: Proceedings of the 13th International Joint Conference on Biomedical Engineering Systems and Technologies. SCITEPRESS - Science and Technology Publications; 2020:337–343. doi:10.5220/0009374503370343.
   Google Scholar
• Laslett LJ, Alagona P, Clark BA, et al. The worldwide environment of cardiovascular disease: prevalence, diagnosis, therapy, and policy issues. J Am Coll Cardiol. 2012;60(25):S1–S49. doi:10.1016/j.jacc.2012.11.002
   PubMed Web of Science ®Google Scholar
• Dunn J, Runge R, Snyder M. Wearables and the medical revolution. Pers Med. 2018;15(5):429–448. doi:10.2217/pme-2018-0044
   PubMed Web of Science ®Google Scholar
• Becker F, van El CG, Ibarreta D, et al. Genetic testing and common disorders in a public health framework: how to assess relevance and possibilities. Eur J Hum Genet. 2011;19(S1):S6–S44. doi:10.1038/ejhg.2010.249
   PubMed Web of Science ®Google Scholar
• Herder M. When everyone is an orphan: against adopting a U.S.-styled orphan drug policy in Canada. Account Res. 2013;20(4):227–269. doi:10.1080/08989621.2013.793120
   PubMed Web of Science ®Google Scholar
• Pirnay JP, Vanderkelen A, De Vos D, et al. Business oriented EU human cell and tissue product legislation will adversely impact Member States’ health care systems. Cell Tissue Bank. 2013;14(4):525–560. doi:10.1007/s10561-013-9397-6
   PubMed Web of Science ®Google Scholar
• Hull G, Pasquale F. Toward a critical theory of corporate wellness. BioSocieties. 2018;13(1):190–212. doi:10.1057/s41292-017-0064-1
   Web of Science ®Google Scholar
• Hall PS, Mitchell ED, Smith AF, et al. The future for diagnostic tests of acute kidney injury in critical care: evidence synthesis, care pathway analysis and research prioritisation. Health Technol Assess. 2018;22(32):1–274. doi:10.3310/hta22320
   Web of Science ®Google Scholar
• Kazzazi F, Pollard C, Tern P, Ayuso-Garcia A, Gillespie J, Thomsen I. Evaluating the impact of Brexit on the pharmaceutical industry. J Pharm Policy Pract. 2017;10(1):32. doi:10.1186/s40545-017-0120-z
   PubMedGoogle Scholar
• Chan JCN, Lim LL, Wareham NJ, et al. The Lancet Commission on diabetes: using data to transform diabetes care and patient lives. Lancet. 2020;396(10267):2019–2082. doi:10.1016/S0140-6736(20)32374-6
   PubMed Web of Science ®Google Scholar
• Dabbous M, Chachoua L, Caban A, Toumi M. Managed entry agreements: policy analysis from the European Perspective. Value Health. 2020;23(4):425–433. doi:10.1016/j.jval.2019.12.008
   PubMed Web of Science ®Google Scholar
• Orubu ESF, Ching C, Zaman MH, Wirtz VJ. Tackling the blind spot of poor-quality medicines in Universal Health Coverage. J Pharm Policy Pract. 2020;13(1):40. doi:10.1186/s40545-020-00208-4
   PubMedGoogle Scholar